MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Combined treatment for lung cancer

Back to lung cancer blog Blogs list Cancer blog  


Subscribe To Lung Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Combined Treatment For Lung Cancer

Combined treatment  for lung cancer
Combining thermal ablation with radiation treatment extends average life expectancy and decreases recurrences of tumors in patients who have early stages of inoperable lung cancer, as per scientists at Rhode Island Hospital.

In a retrospective study looking at patients over seven years, the median survival rate at three years increased from 20 months after radiation alone to 42 months when thermal ablation was followed by radiation for therapy of non-small-cell lung cancer. The results are reported in the recent issue of the Journal of Vascular and Interventional Radiology.

"This study shows us that even patients who are not eligible for surgery can still get very good results," says senior author Damian Dupuy, MD, director of ultrasound at Rhode Island Hospital and professor of diagnostic imaging at Brown Medical School, both in Providence, RI. "By combining thermal ablation and radiation, you have a better chance of survival than with either therapy alone".

With radiation alone, overall survival rates were as follows:
  • one year - 57 percent
  • two years - 36 percent
  • three years - 21 percent
.
With thermal ablation and radiation, they were significantly higher:
  • one year - 87 percent
  • two years - 70 percent
  • three years - 57 percent

Surgery is the standard therapy for lung cancer. However, only one-third of patients with early stage lung cancer qualify for surgery because of other underlying medical conditions. Radiation treatment has long been used for inoperable lung cancer, and more recently, doctors have used radiofrequency ablation (RFA) and microwave ablation, processes that heat tumors to destroy them. For patients who cannot have surgery or radiation, the median survival is about one year.

In this study, scientists looked retrospectively at 41 patients treated over seven years with thermal ablation (RFA or microwave ablation) and either standard radiation treatment or brachytherapy, a procedure in which a "seed" of radioactive material is implanted into the cancer or near it. Patients were diagnosed with Stage I or II lung cancer, meaning the lung cancer in most cases had not spread and was commonly smaller than 3 centimeters, though not in all cases. While this study did not address the timing of combined therapy, brachytherapy radiation was typically administered within two hours of thermal ablation while external beam radiation was given within three to four weeks. Rhode Island Hospital may be the only hospital in the world to administer this combined therapy.

The recurrence rate was much lower with the combined therapy. With radiation treatment alone, about 50 percent of tumors recur within six to 12 months. By the end of this study, 24 percent of patients treated with ablation and radiation had recurrences at an average of 44 months. While there was an increased recurrence rate in larger tumors - 33 percent recurred at an average of 34 months - the overall survival rate was the same for patients with large and small tumors.

"We observed that just because the tumor returns, that doesn't mean the patient lives less long," Dupuy says.

The combined therapys work because they create a "synergy," the authors write. When tumors are targeted with radiation treatment, oxygen is vital to help the radiation damage DNA and kill malignant cells. While radiation is most effective in destroying cells around the edges of the tumor, it is less effective at targeting the center of the tumor, which tends to be a low-oxygen environment.

Thermal ablation, conversely, heats the tumor to kill malignant cells - reaching the center of the tumor, but not necessarily killing all the cells at the edges. This can lead to a recurrence of the tumor, and the cancer may spread. Thermal ablation is delivered directly to malignant cells with the guidance of a diagnostic image showing the tumor's location. However, if some malignant cells have spread into small channels of the lung around the tumor, they tend to be small and not visible on a radiology scan. Thermal ablation, which sends electrical current into the tumor, may not penetrate far enough into the lung to kill these areas of cancer.

When the two therapies are combined, they complement each other. Thermal ablation kills the central tumor. In exchange, radiation kills the cells on the periphery of the tumor and elsewhere in the lung that are missed by thermal ablation.

While this study looked only at lung cancer, Dupuy also has pioneered the use of RFA in thyroid, kidney, adrenal and bone cancer. The combined therapy may have far-reaching effects, Dupuy says.

"You might be able to treat tumors elsewhere in the body with similar results," Dupuy says. "There are a lot of opportunities for exploring the synergy of thermal ablation and radiation".



Posted by: Scott    Source




Did you know?
Combining thermal ablation with radiation treatment extends average life expectancy and decreases recurrences of tumors in patients who have early stages of inoperable lung cancer, as per scientists at Rhode Island Hospital. In a retrospective study looking at patients over seven years, the median survival rate at three years increased from 20 months after radiation alone to 42 months when thermal ablation was followed by radiation for therapy of non-small-cell lung cancer. The results are reported in the recent issue of the Journal of Vascular and Interventional Radiology.

Medicineworld.org: Combined treatment for lung cancer

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.